Free Republic

President Trump on Monday taunted Democratic presidential candidate Joe Biden for effectively refusing his request for a pre-debate drug test. “Joe Biden just announced that he will not agree to a Drug Test. Gee, I wonder why?” Trump tweeted ahead of his first debate with Biden in Cleveland on Tuesday. Biden did not directly refuse Trump’s drug-test request, but his campaign made clear he would not consent to one ahead of the event in Cleveland.

President Trump on Sunday once again called on former Vice President Joe Biden to take a drug test as the two presidential candidates prepare for their first one-on-one face-off in Cleveland. “I will be strongly demanding a Drug Test of Sleepy Joe Biden prior to, or after, the Debate on Tuesday night. Naturally, I will agree to take one also,” the president said in a Twitter post. “His Debate performances have been record setting UNEVEN, to put it mildly. Only drugs could have caused this discrepancy???,” he said. The president has been pressing the Democratic presidential nominee for months about...

He’s giving a whole new meaning to “Morning Joe.” With just 40 days until the presidential election, Joe Biden’s campaign called a lid at the early hour of 9 a.m. Thursday — meaning the Democratic nominee won’t be holding any public events for the rest of the day. Biden’s campaign blasted out the email at 9:20 a.m., announcing the 77-year-old Democratic nominee would spend the day hunkered down in the Wilmington, Delaware, home where he has been sequestered for much of the coronavirus pandemic. His running mate, Sen. Kamala Harris (D-Calif.), also has no public events.

Zeke Miller @ZekeJMiller Biden has called a lid for the day. 6:26 AM · Sep 24, 2020·Twitter Web App

77-year-old Joe Biden emerged from his basement on Sunday and traveled to Philadelphia to give a speech at the Constitution Center. -------snip------ Biden was in really bad shape on Sunday. His labored breathing and claim that 200 million people will die from Covid by the end of his speech today raised eyebrows. After his speech, Biden immediately bolted from the lectern as reporters attempted to ask him questions

Democratic presidential nominee Joe Biden on Tuesday called President Trump "foolish" for his comments on the candidate's mental acuity and unfounded claims suggesting that Biden is taking performance-enhancing drugs, as some pundits are warning that Trump might be lowering expectations for his opponent in the first debate happening later this month. "I'm looking forward to the debate and he's a fool," Biden said in an interview with WFLA 8. "The comments are just foolish. Get ready, Mr. President, here I come." Biden laughed when the WFLA 8 reporter first started asking the question, referencing allegations Trump has made that Biden...

Joe Biden was mocked by viewers last night after pulling out his phone and playing the hit song 'Despacito' at a Hispanic campaign event in Florida. A grinning Biden played the song into a microphone after being introduced by its Puerto Rican-American singer Luis Fonsi at the event in Tampa, as the Democratic nominee seeks Hispanic backing in one of the chief battleground states. But critics accused Biden of 'pandering' and mocked him for playing a song whose title translates as 'Slowly' - evoking Donald Trump's nicknam

Joe Biden has dementia. Aussie reporter Rita Panahi put together an amazing collection of Joe Biden’s recent displays of senility.

FORMER BIDEN CAMPAIGN STAFFER: Joe Biden is in the early stages of dementia and is on medication for it. "This is the big one, and the one I have the least direct experience with, but it’s been an open secret for some time. Anyone who has had a relative with Alzheimer’s or dementia can tell you, there are good days and bad days. On the good days, when Joe is at his most lucid, his campaign manager Jen will send him out for photo ops or TV interviews… make hay while the sun is shining, you know? On the bad...

The drugs now available to treat the memory and thinking problems of Alzheimer's disease have not lived up to the public's high expectations for them and offer such modest benefits on average that many doctors are unsure about whether to prescribe them. Although the drugs have their advocates, grateful for any sign of improvement, others express disappointment in light of earlier hopes that the drugs approved in the last decade would stop the disease or markedly slow it. At a meeting in late March at Johns Hopkins University, doctors and other health professionals heard Alzheimer's researchers debate the usefulness of...